Renoprotective effect of ACE inhibitors: dissecting the molecular clues and expanding the blood pressure goal

Editorial

G Remuzzi. Am J Kidney Dis. 1999 Nov.

. 1999 Nov;34(5):951-4.

doi: 10.1016/S0272-6386(99)70057-0.

No abstract available

Comment on

Effect of intensive blood pressure control on the course of type 1 diabetic nephropathy. Collaborative Study Group.
Lewis JB, Berl T, Bain RP, Rohde RD, Lewis EJ. Lewis JB, et al. Am J Kidney Dis. 1999 Nov;34(5):809-17. doi: 10.1016/s0272-6386(99)70036-3. Am J Kidney Dis. 1999. PMID: 10561135 Clinical Trial.
Captopril-induced reduction of serum levels of transforming growth factor-beta1 correlates with long-term renoprotection in insulin-dependent diabetic patients.
Sharma K, Eltayeb BO, McGowan TA, Dunn SR, Alzahabi B, Rohde R, Ziyadeh FN, Lewis EJ. Sharma K, et al. Am J Kidney Dis. 1999 Nov;34(5):818-23. doi: 10.1016/s0272-6386(99)70037-5. Am J Kidney Dis. 1999. PMID: 10561136 Clinical Trial.